A DEXA Clinical Study to Evaluate the Osteointegrative Potential of Trabecular Titanium™

NCT ID: NCT02635581

Last Updated: 2016-03-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

84 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-12-31

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this clinical trial is to evaluate the osteointegrative potential of the Trabecular TitaniumTM and to measure the pattern of changing in bone mineral density (BMD) around an uncemented acetabular cup, manufactured in Trabecular Titanium™ , during 60 months after surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary Total Hip Replacement

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

DELTA TT

Group Type EXPERIMENTAL

Delta TT acetabular cup

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Delta TT acetabular cup

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* BMI\< 40 kg/m2
* Indication suitable to the implantation of Delta TT acetabular cup (First implant)
* Idiopathic osteoarthritis
* Avascular necrosis
* Post-traumatic arthritis
* Presence of sufficient periacetabular bone stock
* Ability to understand the investigation, cooperate with the investigational procedure and willing to return to the hospital for the required post-operative follow-ups
* Written informed consent

Exclusion Criteria

* Patients found unsuitable for an implantation of Delta TT acetabular cup (Revision)
* Patients aged 76 or older
* Haemophilic disease
* Femur neck fracture
* Insulin Dependent Diabetes Mellitus (IDDM)
* Severe kidney failure (grade 4)
* Not responder Hypo- or Hyperthyroidism
* Paget's disease
* Tumours
* Active or suspicious infections
* Neurosensory deficits or neuromuscular diseases
* Severe and impairing vascular diseases
* Known incompatibility or allergy to products materials
* Woman with pregnancy or childbearing capacity or breast-feeding
* Subjects already enrolled in other clinical trials
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Limacorporate S.p.a

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Leo Massari

Role: PRINCIPAL_INVESTIGATOR

Azienda Ospedaliero-Universitaria di Ferrara, Arcispedale S. Anna

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Azienda Ospedaliero-Universitaria di Ferrara, Arcispedale S. Anna

Cona, Ferrara, Italy

Site Status

Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Dipartimento di Ortopedia, Traumatologia e Riabilitazione, Ospedale CTO, Clinica II

Torino, , Italy

Site Status

Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Dipartimento di Ortopedia, Traumatologia e Riabilitazione, Ospedale CTO, Clinica I

Torino, , Italy

Site Status

Azienda Ospedaliero-Universitaria di Udine, Santa Maria della Misericordia

Udine, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TT-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.